ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of section 122(3) of the Companies Act
Notification in terms of section 122(3) of the Companies Act
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
(“the Company”)
NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(b) OF THE
JSE LISTINGS REQUIREMENTS
In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 (“the Act”) and paragraph
3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that Foord
Asset Management (Pty) Limited has formally notified the Company that it has increased its beneficial
interest in the securities of the Company, which it holds on behalf of its clients, to 5.0% of the ordinary
share capital of the Company, effective 25 August 2020.
Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section
122(3)(a) of the Act.
Durban
26 August 2020
Sponsor:
Investec Bank Limited
Date: 26-08-2020 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
